Societe Generale’s QIAGEN NV QGENF Stock Holding History

Societe Generale’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$152K	Buy	+6,977	New	+$152K	﹤0.01%	2225

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Societe Generale's QGENF Position: Q2 2016 in Review

Societe Generale opened a new position in QIAGEN NV (QGENF) in Q2 2016: 6,977 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #2225 among its holdings.

188 funds tracked by Wall St. Rank hold QGENF as of Q2 2016.

Societe Generale held 6,977 shares of QIAGEN NV worth $152K as of Q2 2016.
QIAGEN NV was a new Societe Generale position in Q2 2016.
QIAGEN NV made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #2225 holding.
188 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.